Equities Research Analysts’ downgrades for Tuesday, February 18th:
Akebia Therapeutics (NASDAQ:AKBA) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Accuray (NASDAQ:ARAY) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) was downgraded by analysts at CIBC from an outperform rating to a neutral rating. The firm currently has C$81.00 price target on the stock, down from their previous price target of C$84.00.
DMC Global (NASDAQ:BOOM) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
BlackRock Long-Term Municipal Advantage Trust’s (LON:BTA) was downgraded by analysts at Citigroup Inc. to a sell rating. They currently have GBX 112 ($1.41) target price on the stock, down from their previous target price of GBX 200 ($2.52).
CorVel (NASDAQ:CRVL) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Crane NXT (NYSE:CXT) was downgraded by analysts at Northland Securities from an outperform rating to a market perform rating. Northland Securities currently has $72.00 price target on the stock.
Datadog (NASDAQ:DDOG) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.
Devon Energy (NYSE:DVN) was downgraded by analysts at Cowen Inc to a hold rating. Cowen Inc currently has $45.00 price target on the stock, down from their previous price target of $46.00.
Forestar Group (NYSE:FOR) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Fortuna Silver Mines (NYSE:FSM) (TSE:FVI) was downgraded by analysts at CIBC from a neutral rating to a sector underperform rating.
Fortuna Silver Mines (TSE:FVI) (NYSE:FSM) was downgraded by analysts at CIBC from a neutral rating to an underperform rating. They currently have C$7.00 price target on the stock, down from their previous price target of C$8.00.
Hims & Hers Health (NYSE:HIMS) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating. Morgan Stanley currently has $60.00 price target on the stock, up from their previous price target of $42.00.
Robinhood Markets (NASDAQ:HOOD) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.
Interpublic Group of Companies (NYSE:IPG) was downgraded by analysts at Argus from a buy rating to a hold rating.
Leslie’s (NASDAQ:LESL) was downgraded by analysts at Bank of America Co. from a buy rating to an underperform rating. The firm currently has $1.40 target price on the stock, down from their previous target price of $2.65.
Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating. They currently have $105.00 price target on the stock, down from their previous price target of $128.00.
Moderna (NASDAQ:MRNA) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating. Barclays PLC currently has $45.00 target price on the stock, down from their previous target price of $111.00.
Neurocrine Biosciences (NASDAQ:NBIX) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.
PG&E (NYSE:PCG) was downgraded by analysts at Guggenheim from a buy rating to a neutral rating.
Portland General Electric (NYSE:POR) was downgraded by analysts at LADENBURG THALM/SH SH from a buy rating to a neutral rating. The firm currently has $42.00 price target on the stock.
Septerna (NASDAQ:SEPN) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. Wells Fargo & Company currently has $14.00 price target on the stock.
Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating.
Toronto-Dominion Bank (TSE:TD) (NYSE:TD) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. They currently have C$99.00 target price on the stock, up from their previous target price of C$90.00.
TriNet Group (NYSE:TNET) was downgraded by analysts at TD Cowen from a buy rating to a hold rating. They currently have $74.00 target price on the stock, down from their previous target price of $104.00.
Universal Electronics (NASDAQ:UEIC) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.
Veracyte (NASDAQ:VCYT) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Receive News & Ratings for Akebia Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akebia Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.